Patent granted for MS drug Tecfidera (BG-12) until 2028

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.

Patent granted for MS drug Tecfidera (BG-12) until 2028

Postby MSUK » Wed Mar 20, 2013 1:08 am

Patent granted for Multiple Sclerosis drug Tecfidera (BG-12) until 2028

Biogen Idec Inc announces it has been granted a new patent that will help protect the market exclusivity of its multiple sclerosis drug Tecfidera (BG-12) until 2028.

The new patent covers the dosing regimen for Tecfidera of 480 milligrams a day....Read more -
User avatar
Family Elder
Posts: 2728
Joined: Wed Oct 14, 2009 2:00 pm


Return to Tecfidera (BG-12, dimethyl fumarate)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service